Sensitivity of Targeted Biopsy Within Sydney Protocol for GIM

Last updated: April 5, 2021
Sponsor: King Chulalongkorn Memorial Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Precancerous Condition

Treatment

N/A

Clinical Study ID

NCT04331951
RP016
  • Ages > 18
  • All Genders

Study Summary

Sensitivity of Targeted Biopsy Within Sydney Protocol by Using Narrow Band Imaging for Extensive Gastric Intestinal Metaplasia Diagnosis

Objective:

The aim of this study is to evaluate the sensitivity of targeted biopsy within Sydney protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis

Research design: Diagnosis study

Sample size: 105 cases

Data analysis:

The outcomes will be presented using 2 by 2 tables and if the data are normal distribution the categorical data will be analysed using McNemar's test

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • At least 18 year of age
  • Suspected GIM by previous tissue pathology
  • Able to provide informed consent for participation

Exclusion

Exclusion Criteria:

  • Previous gastric surgery including gastrectomy and bypass surgery
  • Coagulopathy
  • Pregnancy
  • Active upper GI bleeding

Study Design

Total Participants: 105
Study Start date:
November 01, 2019
Estimated Completion Date:
October 31, 2021

Study Description

Background and Rationale:

Gastric cancer has been in the top-5 of cancer-related death worldwide. Early detection by screening program in high risk patients is very important. If we can detect pre-malignant lesion eg. gastric intestinal metaplasia, we can provide the appropriate surveillance program to those patients. However, the screening protocol for gastric intestinal metaplasia remained unclear. Recently in July 2019, British Society of Gastroenterology published the guideline on the diagnosis and management of patients at risk of gastric adenocarcinoma. The image-enhanced endoscopy (IEE) is recommended as the best modality for assessing gastric intestinal metaplasia. Additionally, they recommended taking biopsy by using Sydney protocol which means taking biopsy at two areas for antrum, two areas for body and one for incisura although they look normal. We aimed to evaluate the sensitivity of this protocol for extensive gastric intestinal metaplasia (GIM) diagnosis in this study.

Methodology:

  • All patients with history of GIM will be enrolled and undergone standard with white light esophagogastroduodenoscopy (EGD).

  • Those with suspected lesions of GIM will proceed to narrow band imaging (NBI)-mode endoscopy.

  • Targeted biopsy will be done at the suspected GIM lesions. Random biopsy will be while will be done if no suspicious GIM lesion seen.

Data collection:

All data will be processed and recorded by one physician.

Connect with a study center

  • King Chulalongkorn Memorial Hospital

    Bangkok, 10330
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.